Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-461 in Advanced Renal Cell Cancer
NCT00036036Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2001
- Countries
- 1
01
Overview
A Phase 2 trial of CP-461 in renal cell carcinoma (RCC), sponsored by Astellas Pharma. Started Jul 2001; status: completed.
02
Drugs
CP-461
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00036036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036036.